AUTHOR=Bekri Selma , Bourdely Pierre , Luci Carmelo , Dereuddre-Bosquet Nathalie , Su Bin , Martinon Frédéric , Braud Véronique M. , Luque Irene , Mateo Pedro L. , Crespillo Sara , Conejero-Lara Francisco , Moog Christiane , Le Grand Roger , Anjuère Fabienne 

TITLE=Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates

JOURNAL=Frontiers in Immunology

VOLUME=Volume 8 - 2017

YEAR=2017

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2017.00063

DOI=10.3389/fimmu.2017.00063

ISSN=1664-3224

ABSTRACT=Persistent B cell responses in mucosal tissues are crucial to control infection against sexually transmitted pathogens like Human Immunodeficiency Virus 1 (HIV-1). The genital tract is a major site of infection by HIV. Sublingual immunization in mice was previously shown to generate HIV-specific B cell immunity that disseminates to the genital tract. We report here the immunogenicity in female cynomolgus macaques of a sublingual vaccine based on a modified gp41 polypeptide coupled to the cholera toxin B subunit designed to expose hidden epitopes and to improve mucosal retention. Combined sublingual/intramuscular immunization with such muco-adhesive gp41-based vaccine elicited mucosal HIV-specific IgG and IgA antibodies more efficiently than intramuscular immunization alone. This strategy increased the number and duration of gp41-specific IgA secreting cells. Importantly,  combined immunization improved the generation of functional antibodies three months after vaccination as detected in HIV-neutralizing assays. Therefore, sublingual immunization represents a promising vaccine strategy to block HIV-1 transmission.